Kilimanjaro Clinical Research Institute

Kilimanjaro Clinical Research Institute
KCRI LOGO (8)

Kilimanjaro Clinical Research Institute (KCRI) is a leading health research institution based in Moshi, northern Tanzania, dedicated to conducting high-quality biomedical, clinical, and public health research. The institute collaborates closely with national and international academic institutions, government agencies, and global health organizations to address priority health challenges in Tanzania and beyond. KCRI has extensive experience in infectious diseases including zoonoses, antimicrobial resistance, non-communicable diseases, maternal and child health, vaccinology, genomics, and implementation science. The institute operates state-of-the-art, Good Clinical Laboratory Practice (GCLP)-accredited research laboratories equipped for microbiology, molecular biology, clinical chemistry, hematology, parasitology, immunology, genomics, and biobanking, supported by experienced multidisciplinary scientists and research support staff.

The study is being conducted at Kilimanjaro Christian Medical Centre (KCMC), a tertiary referral hospital in northern Tanzania, under the coordination KCRI. The pilot site recruits adult patients from four therapeutic areas: cardiovascular diseases, endocrinology, immunology, and oncology. The target population comprises adult patients receiving care at KCMC for hypertension, type 2 diabetes mellitus, HIV infection, or cancer. These patient groups were selected because chronic disease management requires sustained adherence to medication and treatment plans, and non-adherence can lead to poorer clinical outcomes, increased healthcare utilization, and reduced quality of life.

Kilimanjaro Clinical Research Institute (KCRI) is a leading health research institution based in Moshi, northern Tanzania, dedicated to conducting high-quality biomedical, clinical, and public health research. The institute collaborates closely with national and international academic institutions, government agencies, and global health organizations to address priority health challenges in Tanzania and beyond. KCRI has extensive experience in infectious diseases including zoonoses, antimicrobial resistance, non-communicable diseases, maternal and child health, vaccinology, genomics, and implementation science. The institute operates state-of-the-art, Good Clinical Laboratory Practice (GCLP)-accredited research laboratories equipped for microbiology, molecular biology, clinical chemistry, hematology, parasitology, immunology, genomics, and biobanking, supported by experienced multidisciplinary scientists and research support staff.

The study is being conducted at Kilimanjaro Christian Medical Centre (KCMC), a tertiary referral hospital in northern Tanzania, under the coordination KCRI. The pilot site recruits adult patients from four therapeutic areas: cardiovascular diseases, endocrinology, immunology, and oncology. The target population comprises adult patients receiving care at KCMC for hypertension, type 2 diabetes mellitus, HIV infection, or cancer. These patient groups were selected because chronic disease management requires sustained adherence to medication and treatment plans, and non-adherence can lead to poorer clinical outcomes, increased healthcare utilization, and reduced quality of life.